Objectives: To know the incidence and characters of insulin resistance (lR) in polycystic ovaries (PCO) patients, and the efficacy of metformin treatment for induction of ovulation compared to clomiphene citrate (CC); also the effect of .metformin on the clinical, biochemical and hormonal features of the patient would be evaluated.
INTRODUCTION
Hyperinsulinernia and hypcrandrogenernia are thought to be causative factors.
Metformin
IS a biguanide oral anti hyperglycemic drug which Improves insulin sensitivity and lowers blood glucose and serum insulin levels(6). Treatment of insulin resistant PCO patients with mctformin combined with CC has been claimed to result in higher ovulation and pregnancy rates.
Metfonnin treatment in insulin resistant PCO
The aims of this work was: A ratio of fasting blood glucose to fasting serum insulin (GIl ratio) of less than 4.5 rng/IO'" unit was considered insulin resistance (IR)(9}.
IR patients were randomly allocated for induction of ovulation with one of the following regimens for three cycles:
I. CC IOOmg daily from cycle day 5-9+ metformin 1500 mg daily through out the cycle.
2. Placebo from cycle day 5-9 + metfonnin 1500 mg daily through out the cycle.
3. CC ] 00 mg daily from cycle day 5-9 + placebo through out the cycle. After three treatment cycles, the ovulation and pregnancy rates were calculated, and the effect of metformin treatment on the BMI, the hirsutism and the acne scores, the fasting blood glucose, the fasting serum insulin and serum testosterone levels were recorded.
Statistical Methods:
Results were statistically analyzed using the mean, the standard deviation, the student-t test and the paired-t test. The result was considered significant if its P value was < 0.05.
RESULTS

DISCUSSION
In our study, serum testosterone level was significantly higher in IR, PCO patients (P < 0.05).
This result agrees with that reported by most authors' 16, 17). Hyperinsulinemia causes increased ovarian androgen secretion through different mechanisms:
Other causes of hyperinsulinernia in pea patients could be increased pancreatic secretion of insulin resulting from genetic mutation(l4) or a defect in glucose transport(l5).
Insulin by acting via its own receptors(18) or via insulin like growth factor-I (IGF-I) receptors'I'" stimulates ovarian production of androgens.
Others ( In the present study, the BMI was significantly higher in IR than in non IR patients (P < 0.05); this Hirsutism and acne are markers for increased androgen production, but it does not occur in all hyperandrogenic pea patients. In our study, there was no significant difference between the incidence of either hirsutism or acne in IR and non IR patients. remains patients PCO in Sixty peo patients were studied, 52 patients (86.6%) had a fasting blood glucose level I fasting serum insulin level less than 4.5 mg/IO-4, which is consistent with IR, while 8 patients were non IR (13.4%). Table V: shows that the highest ovulation and pregnancy rates were in the CC + metformin group, followed with metformin + placebo group, while the lowest were in the CC + placebo group. (23) who found that IR was present in 30% of slim and in 75% of obese women with PCO.
In our study, the highest ovulation and pregnancy rates were in patients treated with CC + metformin followed by metformin then by Cc.
This result agrees with that reported by several authors (24, 25, 26, 27) . On the other hand, some authors(28,29) failed to find any beneficial effect of metformin treatment. An interesting result in our study was that the ovulation and pregnancy rates increased with longer duration of metformin treatment, in contrast with ec alone treatment, where both parameters decreased. This result was not reported in previous studies.
In the present study, there were a significant decrease in fasting serum insulin and serum testosterone levels after metformin treatment compared to pre treatment levels. These results The degree of hirsutism associated with pea does not correlate only with the concentration of circulating androgens but also on the genetic sensitivity of the hair follicle(37).
CONCLUSIONS
Insulin resistance must be diagnosed in PCO patients. treatment with metformin decreases serum insulin and serum testosterone levels.
Combined CC + metformin results in higher ovulation and pregnancy rates. In contrast with CC, the longer the duration of metforrnin treatment, the better are the results. Co-administration of mctformin during rFSH 
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